Dymista (Azelastine hydrochloride & Fluticasone propionate)
| Medication | Dose | Time | Essential |
|---|---|---|---|
| Levothyroxine sodium | 50 µg | Morning | ✓ |
| Levetiracetam | 250 mg × 2 | Morning + Evening | ✓ |
| Bisoprolol fumarate | 2.5 mg | Morning | ✓ |
| Ramipril | 2.5 mg + 5 mg | 2.5 mg morning, 5 mg evening | ✓ |
| Clopidogrel | 75 mg | Evening | ✓ |
| Co-Trimoxazole | 80/400 mg | Evening | ✓ |
| Atorvastatin | 10 mg | Evening | ✓ |
| Esomeprazole | 20 mg | Afternoon | If needed |
| Virgan eye gel (ganciclovir 0.15%) | 1 drop LEFT EYE only | Evening | ✓ |
| ADCAL D3 (calcium + cholecalciferol) | 750 mg / 200 IU | Evening | Not essential |
| Marker | Value | Status |
|---|---|---|
| eGFR | 39 mL/min | LOW (was 46 in June 2025) |
| Creatinine | 124 µmol/L | HIGH (was 109) |
| HbA1c | 56 mmol/mol | Borderline (target <53) |
| CRP | <1.0 mg/L | Normal |
| Sodium | 129 mmol/L | LOW |
| Potassium | 4.7 mmol/L | Normal |
| Cholesterol (total) | 8.8 mmol/L | HIGH |
| LDL Cholesterol | 6.4 mmol/L | HIGH |
| HDL Cholesterol | 1.9 mmol/L | Good |
| Lipoprotein(a) | 110 nmol/L | HIGH (genetic) |
| ALT | 25 U/L | Normal |
| Vitamin D | 56.3 nmol/L | Adequate |
Sept 2024: Total heart block — pacemaker fitted 3/9
Sept–Oct: Left ear mastoiditis — grommet fitted 17/10
Nov 2024: Vasculitis diagnosed (heart, liver, kidney involvement)
Treatment: Cyclophosphamide (completed Jan 2025) + Rituximab (3 doses, last June 2025)
June 2025: CT lungs normal. MRI heart fine.
Current: Liver markers normalised. Heart and kidneys not yet normal.
Scleroderma (1990): In remission — limited mouth opening, flexed hands
Wegener's Granulomatosis (1998): In remission — fragile nose (2 operations)
Endometrial cancer (2012): In remission — chemo & radiotherapy
Seizures: Controlled by Levetiracetam
Type 1 Diabetes: Monitored by Dexcom, controlled by insulin
Pacemaker (2024): PROPONENT MRI EL DR